Update 2008, Q3 Live!

₃F Etcharry-Bouyx

Summary for 2003 [at-glance overview of F Etcharry-Bouyx work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author F Etcharry-Bouyx. According to available data, in 2003 F Etcharry-Bouyx published at least 3 articles. This work was completed in collaboration with several authors including Dubas, F and Gohier, B. Several other authors have collaborated with F Etcharry-Bouyx as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that F Etcharry-Bouyx professional interests are focused around "delirium delusion depression", "acute delirium delusion" and "ifn-beta-1a therapy ms". These might also be referred to as "ifn-beta-1a therapy", "multiple sclerosis" or "delirium delusion". Statistical analysis shows that F Etcharry-Bouyx's writing is likely to contains terms "ifn-beta-1a", "case", "therapy", "leucodystrophy", "orthochromatic" and "report".

Unfortunately, there is not enough information to establish F Etcharry-Bouyx affiliation. Luckily, one email address is on file.

EN FR ES RU

leave comment ask question

Other [context-specific ads]

Alternative names (0) [other authors with names similar to F Etcharry-Bouyx]

none

Year 2003 Charts [F Etcharry-Bouyx frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of F Etcharry-Bouyx publication and funding history for the range of years]

Emails (1) [email addresses extracted from F Etcharry-Bouyx affiliations]

hidden to prevent spam, click here to reveal

F Etcharry-Bouyx Coauthors (6) [all coauthors with the number of joint publications]

2

1

1

1

1

1

Affiliations (3) [condensed summary of the F Etcharry-Bouyx affiliations, the leading number and the color conveys importance]

₁Cell Biology Laboratory, CHU, 49033 Angers, France. Department of Neurology, CHU, 49033 Angers, France.
₁Unité de Neuropsychologie, Département de Neurologie, CHU d'Angers, France.
₁Service de psychiatrie, Centre Hospitalier Universitaire, Angers, France.

Key Opinion Leader In [F Etcharry-Bouyx is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (22) [keywords assigned to F Etcharry-Bouyx articles by PubMed, the leading number and the color conveys importance]

₃Humans | ₂Male | ₂Adult | ₁Multiple Sclerosis | ₁Adjuvants, Immunologic | ₁Leukodystrophy, Metachromatic | ₁Age of Onset | ₁Female | ₁Neurologic Examination | ₁Diagnosis, Differential | ₁Middle Aged | ₁Magnetic Resonance Imaging | ₁Interferon-beta | ₁Depression | ₁Delusions | ₁Apraxia, Ideomotor | ₁Apraxias | ₁Delirium | ₁Genes, Dominant | ₁Brain | ₁Pedigree | ₁Phenotype

F Etcharry-Bouyx Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; F Etcharry-Bouyx might be a good expert witness on these terms]

₆ifn-beta-1a | ₅case | ₅therapy | ₅leucodystrophy | ₅orthochromatic | ₄report | ₄ms | ₃features | ₃sclerosis | ₃cases | ₃delirium | ₃acute | ₃depression | ₃multiple | ₃psychiatric | ₃delusion | ₃clinicopathological | ₃onset | ₂patient | ₂established | ₂treatment | ₂patients | ₂signs | ₂effects | ₂aged | ₂mri | ₂inherited | ₂dementia | ₂years | ₂dominantly | ₂adult | ₂epilepsy
₄ifn-beta-1a therapy | ₃multiple sclerosis | ₃delirium delusion | ₃delusion depression | ₃acute delirium | ₃orthochromatic leucodystrophy | ₂therapy ms | ₂leucodystrophy clinicopathological | ₂depression ifn-beta-1a | ₂dominantly inherited | ₂therapy multiple | ₂sclerosis case | ₂cases dominantly | ₂case report | ₂onset orthochromatic | ₂aged years | ₂dementia epilepsy | ₂clinicopathological cases | ₂inherited adult | ₂adult onset | ₁psychotic symptoms | ₁mri findings | ₁histopathological features | ₁relapsing-remitting multiple | ₁taking ifn-beta-1a | ₁vulnerability patients | ₁ms developed | ₁main characteristics | ₁flair sequences | ₁ceased treatment | ₁established patient | ₁orthochromatic type
₃delirium delusion depression | ₃acute delirium delusion | ₂ifn-beta-1a therapy ms | ₂clinicopathological cases dominantly | ₂multiple sclerosis case | ₂dominantly inherited adult | ₂therapy multiple sclerosis | ₂leucodystrophy clinicopathological cases | ₂adult onset orthochromatic | ₂ifn-beta-1a therapy multiple | ₂onset orthochromatic leucodystrophy | ₂delusion depression ifn-beta-1a | ₂inherited adult onset | ₂sclerosis case report | ₂cases dominantly inherited | ₂depression ifn-beta-1a therapy | ₁histopathological features | ₁characteristics probably autosomal | ₁dementia epilepsy aged | ₁multiple sclerosis ms | ₁matter mri findings | ₁report adverse effects | ₁adverse effects interferon | ₁ifn treatment common | ₁ifn-beta-1a established therapy | ₁developed acute delirium | ₁side effects debated | ₁type heterogeneous group | ₁recurrent major depressive | ₁known enzyme deficiency | ₁fully established patient | ₁ms developed acute

Reader's Comments (0) [comments posted by readers of F Etcharry-Bouyx profile]